Chairman, CEO and President of Female Health Company (FHCO, Financial) O B Parrish sells 25,000 shares of FHCO on 09/18/2009 at an average price of $5.53 a share.
The Female Health Company manufactures markets and sells the Female Condom the only FDA-approved product under a woman's control which can prevent unintended pregnancy and sexually transmitted diseases including HIV/AIDS. It is the only HIV/AIDS product specifically developed and approved by regulatory agencies in the U.S. the European Union Japan and The People's Republic of China among others since the epidemic beganabout twenty years ago for the prevention of the transmission of HIV/AIDS through sexual contact. Female Health Company has a market cap of $151.74 million; its shares were traded at around $5.53 with a P/E ratio of 24.04 and P/S ratio of 5.92.
Recent Trades of Female Health Company by CFO:
Recent Trades of Female Health Company by Directors and Officers:
Verify Chart
Recent Trades of Female Health Company by CFO:
- Sell: Vice President and CFO Donna Felch sold 10,000 shares of FHCO stock on 08/19/2009 at the average price of $7.1; the price of the stock has decreased by 22.11% since.
Recent Trades of Female Health Company by Directors and Officers:
- Sell: VP and General Manager Michael Pope sold 16,700 shares of FHCO stock on 09/16/2009 at the average price of $5.61; the price of the stock has decreased by 1.43% since.
- Sell: VP and General Manager Michael Pope sold 40,000 more shares of FHCO stock on 09/15/2009 at the average price of $5.74; the price of the stock has decreased by 3.66% since.
- Sell: VP and General Manager Michael Pope sold 15,000 more shares of FHCO stock on 09/14/2009 at the average price of $5.82; the price of the stock has decreased by 4.98% since.
- Sell: Vice President-General Manager Michael Pope sold 19,250 more shares of FHCO stock on 08/26/2009 at the average price of $7.51; the price of the stock has decreased by 26.36% since.
- Sell: Director, 10% Owner Stephen M Dearholt sold 20,000 shares of FHCO stock on 08/20/2009 at the average price of $7; the price of the stock has decreased by 21% since.
